Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by NeonMind Biosciences Inc. NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows April 12, 2022 From NeonMind Biosciences Inc. Via AccessWire Tickers CSE:NEON NMDBF NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference December 02, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers CSE:NEON NMDBF NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001 November 23, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers CSE:NEON NMDBF NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021 November 17, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property Tickers CSE:NEON NMDBF NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments November 08, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers CSE:NEON NMDBF NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine November 05, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers CSE:NEON NMDBF NeonMind Advances Strategy for Specialty Clinic Launch September 28, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Tickers CSE:NEON NMDBF NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD. September 22, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers CSE:NEON NMDBF NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board September 16, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers CSE:NEON NMDBF NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets September 13, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers CSE:NEON NMDBF NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference September 08, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers CSE:NEON NMDBF NeonMind Announces DTC Eligibility August 25, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers CSE:NEON NMDBF NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation 'Mindful Blend' August 17, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers CSE:NEON NMDBF NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division August 05, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers CSE:NEON NMDBF Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board July 28, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers CSE:NEON NMDBF NeonMind Provides Integrated Drug Development Plan Update for NEO-001 to Treat Obesity July 21, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers CSE:NEON NMDBF NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US June 29, 2021 From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers CSE:NEON NMDBF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
